Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Omnicell
AddedFeb 17, 2024
UpdatedJun 28, 2026
Omnicell

Omnicell

Public

Omnicell, Inc. offers integrated clinical infrastructure and workflow automation solutions for healthcare facilities.

HQ
Mountain View, CA, US
Founded
1992
Overview
Compare
Fundraising
Employees
Website

Omnicell, Inc., founded in Mountain View, United States, focuses on providing integrated clinical infrastructure and workflow automation solutions for healthcare facilities. The company's core mission is to enhance patient care and operational efficiency through innovative technology. Omnicell's product offerings include pharmacy and supply systems, clinical reference tools, internet-based procurement applications, and decision support systems. Their market focus spans a range of healthcare facilities, including hospitals and outpatient clinics.

Notable affiliated people include Randall Lipps, the founder, who has been instrumental in driving the company's vision. Omnicell has attracted significant investment and partnerships, contributing to its growth and innovation in healthcare technology. Key achievements include the widespread adoption of their automated medication management systems, which have significantly improved patient safety and operational efficiency in healthcare settings. Overall, Omnicell has made a substantial impact on the healthcare industry by streamlining processes and enhancing the quality of care through automation.

Omnicell - Quick Facts

When was Omnicell founded?

Omnicell was founded in 1992.

Where is Omnicell's headquarters located?

Omnicell's headquarters is located in Mountain View, CA, US.

How much has Omnicell raised to-date?

As of Jan 1, 2001, Omnicell has raised a total of $20M (USD).

How many employees does Omnicell have?

Omnicell has 3,800 employees as of Feb 6, 2024.

Omnicell - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Automation
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Automation
  • Healthcare
Tags
  • Healthtech
Unique IDs
  • ein: 943166458
  • secCik: 0000926326
  • ticker: OMCL
NAICS
  • 334100Computer and Peripheral Equipment Manufacturing
  • 334111Electronic Computer Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 334110Computer and Peripheral Equipment Manufacturing
SIC
  • 3571Electronic computers
  • 3500Industrial And Commercial Machinery And Computer Equipment
  • 3570Computer And Office Equipment
ISIC
  • 2620Manufacture of computers and peripheral equipment
Show 20 more industry codes
NAICS
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 339000Miscellaneous Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3841Surgical And Medical Instruments And Apparatus
  • 4000Railroad Transportation
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 3250Manufacture of medical and dental instruments and supplies